Exelixis (EXEL) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

EXEL is expected to report earnings to fall 59.52% to 34 cents per share on October 30

Q3'24

Est.

$0.34

Q2'24

Beat

by $0.53

Q1'24

Missed

by $0.06

Q4'23

Beat

by $0.10

Q3'23

Missed

by $0.05

The last earnings report on August 06 showed earnings per share of 83 cents, beating the estimate of 31 cents. With 1.18M shares outstanding, the current market capitalization sits at 7.50B.

View a ticker or compare two or three

Compare

EXEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EXEL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for EXEL (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1851 Harbor Bay Parkway

Phone

+1 650 837-7000

Employees

1310

Web

https://www.exelixis.com